Raise and Invest Capital.
Welcome To MAZAKALI
Capital Management Beyond Impact
MAZAKALI’s leadership team began putting capital to work in plant-based medicine (PBM) in 2014. Today, we offer full scale digital capital raising and investment services across the hemp, non-hemp cannabis and psychedelics industries.
A Registered Investment Adviser, MAZAKALI offers customized, Separately Managed Accounts (SMAs) to pioneering investors. Operators and issuers work with licensed Investment Bankers to utilize our Capital Advisory and M&A services. Both come together on our digital capital platform. Securities are offered via a licensed Broker/Dealer.
MAZAKALI was founded with a passion and purpose for transforming the health of our plants, our people, our planet and our portfolios through the responsible and ethical allocation of capital. Our clients have a similar mindset.
Authority Through Knowledge
GreenPapers®. Infused drinkables currently hold a market share of under 1% in the US, a figure that is far too low when compared with industry estimates for a $2.8 billion global cannabis beverage market by 2025. Advances in cannabis science along with the thirst for a healthier alternative to alcohol are but two factors behind this anticipated growth..[…] May 2020
GreenPapers®. An industry with over 40,000 businesses and in excess of 240,000 employees has witnessed the lion’s share of capital and media attention going to the fewer than 400 public companies, leaving over 99% of the industry to innovate, compete and grow with an abundance of capital and advertising restrictions.
GreenPapers®. The cannabis complex continues its roller coaster ride toward full legalization with many important milestones marking the significant progress we have made over the years. Important scientific discoveries, meaningful regulatory changes, supportive capital markets and incredible product innovations have rapidly fueled our industry to a place of public acceptance and support quite unimaginable just a decade ago. […] May 2020
Exploring Cannabis Investments?
MAZAKALI is a Registered Investment Adviser and provides access to direct investment opportunities as well as managed investment services such as SMAs (Separately Managed Accounts) and third-party funds for investors. Investors in cannabis since 2014, MAZAKALI provides an investment marketplace for industry players with highlighted securities offerings by licensed investment bankers via our Broker/Dealer. Connect with companies, make direct investments, or rely on our OCIO (Outsourced Cannabis Investment Officer) services for portfolio advisory and management.
Raising Cannabis Capital?
How would you rate your capital readiness? Are you prepared to raise capital? Do you have a financial model, a multi-year pro-forma, a valuation, a term sheet and a pitch deck? Explore MAZAKALI’s Capital Advisory services to boost your capital readiness.
Do you have an attractive digital “store front” for your investment offering? Build a digital offering with multimedia capabilities, a complete data room, appropriate firewalls, unlimited secure storage, communication and collaboration tools, electronic execution and complete investor behavioral transparency.
Helping Others Raise Capital?
Ideal for alternative investment managers, broker-dealers, capital advisory firms, incubators, accelerators and virtual conferences. Provide a seamless, mobile-friendly investment experience while maintaining control and customization. Private-Label our investment platform to your specifications. Increase revenue and save time via value, volume and velocity. Contact Us
With Privilege Comes Responsibility
As early entrants and investment leaders, we are driven by a passion and belief that purposeful cannabis and plant based medicine investment will play a significant role Beyond Impact.
MAZAKALI LLC (“MAZAKALI”) is an investment adviser registered with the state of California and is not a registered broker dealer. MAZAKALI’s principal, Sumit Mehta is an investment adviser representative of MAZAKALI and is also separately registered as an associated person of Growth Capital Services, Inc., a licensed broker-dealer and member of FINRA/SIPC (“GCS”), office of supervisory jurisdiction located at 582 Market Street, Suite 300, San Francisco, CA 94104. GCS and Mazakali are separate entities, and only certain securities brokered by Sumit Mehta are offered and sold through GCS. You can find more information about GCS and Mr. Mehta here and through FINRA Broker check.
Investment advisory services are provided exclusively from MAZAKALI’s San Francisco office. Registration as an investment adviser does not imply any particular skill or training. Any securities offered by Mr. Mehta are offered through GCS pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended (“Securities Act”), and such private placements are not subject to the disclosure requirements that apply to registered securities under the Securities Act. Unregistered securities, and investments in the cannabis industry in particular, are speculative, and considered by regulators to involve a high degree of risk. Any descriptions of securities or companies on the MAZAKALI website do not constitute a recommendation, solicitation, or investment advice by MAZAKALI, GCS or its registered representatives, including Mr. Mehta.
Any statements other than those of historical fact are estimates only, and not an indication of any future investment performance. Past performance is not a guarantee of future results. Moreover, none of MAZAKALI, GCS, or any of its registered representatives makes any representation, warranty or guaranty of any kind, express or implied, as to the accuracy, completeness or reasonableness of the information contained on the MAZAKALI website, or of any other written or oral communication transmitted or made available to any interested party.
Offerings and services may only be available to certain investor types, classes and/or groups, depending upon the type of offering, various regulatory requirements, and/or the preferences of the issuer and their advisers; including, but not limited to, limiting deal access or investment capability to accredited investors. In the most sensible investment strategy, alternative investments should only be part of your overall investment portfolio. Potential investors are advised to consult with their tax, legal and financial advisors before making any investment.